AEGiS-GMHC: TREATMENT BRIEFS: AIDS Research Budget Reduced Gay Men's Health CrisisImportant note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.
Click here to return to Gay Men's Health Crisis main menu
DonateNow
Print this Article


TREATMENT BRIEFS: AIDS Research Budget Reduced

TREATMENT ISSUES, Volume 6, Number 9 - October 1992; The Gay Men's Health Crisis Newsletter of Experimental Therapies
David Gold


Despite the expansive spread of HIV in the U.S. land the world), actual funding for HIV/AIDS research at the National Institutes of Health (NIH) is being reduced. In 1992, the NIH AIDS budget was set at $841 million. For 1993, the President's budget proposed $873 million, although the NIH had requested $1.195 billion. The apparent 3.8% increase in the 1993 budget ends up to represent a reduction in funds, given the following: a 12% biomedical inflation rate; a total federal budget increase of 13%; and mandates to stretch research dollars to areas such as pediatrics, TB, and preventative vaccines. Incredibly, the House of Representatives reduced the President's pitiful figure even further--leaving only $864 million. The Senate has now proposed a figure similar to the President's, and a House-Senate conference committee will decide on a budget somewhere between $864-873 million.

We must examine closely our own failure to advocate effectively for an AIDS research budget. Some notable exceptions spring tv mind, such as Project Inform's research lobbying efforts, United for AIDS Action's political organizing and voter registration efforts, and AIDS Action Council finally hiring a treatment/research specialist (the talented Derek Hodel). However, if truly effective therapies for HIV are to be developed, our overall efforts on behalf of a well-funded and guided AIDS research program need to be reviewed and expanded.

Copyright (c) 1992 - Gay Men's Health Crisis. Non-commercial electronic dissemination encouraged. Distributed by AEGIS, your online gateway to a world of people, knowledge, and resources. Direct Dial: v.34+: 714.248.2836; v.120/ISDN: 714.248.0433 Internet: telnet:aegis.com www: www.aegis.com


9210
GM060906


Copyright © 1992 - Treatment Issues. Reproduced with permission. Treatment Issues is published twelve times yearly by GMHC, Inc. All rights reserved. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. GMHC Treatment Issues, The Tisch Building, 119 West 24th Street, New York, NY 10011  fredg@gmhc.org  http://www.gmhc.org

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .